Xeris Biopharma (XERS) AI Analysis

XERS$16.80—
BiotechnologyGrowth StockHigh Quality
Compare
Market cap$3.10BEnterprise value—Revenue (TTM)$368.26MMarket position—

Score

65
Bullish
Value
32
Quality
70
Growth
94

Xeris Biopharma Holdings is a growth-led story right now — Growth 94/100 is the pillar doing the heavy lifting (overall 65/100) in Biotechnology. Under the hood: revenue compounding ~39% annually over recent years. Street targets still imply ~11% below the current price.

Xeris Biopharma (XERS) AI Analysis

XERS price $16.80 —

Ticker
XERS
Price
$16.80
Change
—
Market cap
$3.10B
Forward P/E
42.07
Dividend yield
0.00%
Beta
0.84
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
65
Value
32
Quality
70
Growth
94

Stocklytics score rationale: value 32, quality 70, growth 94.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener